Skip to content

Comparison of Continuous Sternal ECG Patch Monitors (Carnation and Zio) Trial

Comparison of Continuous Sternal ECG Patch Monitors (Carnation and Zio) Trial

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02952781
Enrollment
30
Registered
2016-11-02
Start date
2016-10-31
Completion date
2017-01-31
Last updated
2017-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation, Presyncope, Supraventricular Tachycardia, Syncope

Keywords

ECG Monitoring, Palpitations

Brief summary

The purpose of this research is to test the clinical value of a new P-wave sensitive recording vector compared to a standard ECG limb lead II vector from similar easy-to-use long-term cardiac rhythm monitoring patch systems, the Carnation TM Ambulatory Monitoring (CAM) System and the Zio-XT iRhythm. The P-wave is a critical aspect of the electrocardiogram. The purpose of this study is to see if the P-wave centric focus of the CAM system improves arrhythmia diagnosis.

Detailed description

This study is intended to compare the new Carnation patch monitoring system with the Zio patch, which represents the current standard for continuous recording of the ECG over extended periods. The primary endpoint for this comparison will be diagnostic yield with secondary endpoints being ease of use and comfort.

Interventions

DEVICEEKG Patch monitors (Zio and Carnation)

Each patient will be provided with both a Zio-XT Patch monitoring system and the CAM system and will be instructed to wear both simultaneously for 7 days.

Sponsors

EvergreenHealth
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male or female * Written informed consent * Patients with one or more of the following: * Syncope of uncertain etiology; or * Pre-syncope of uncertain etiology; or * Palpitations of uncertain etiology; or * Management of known AF/SVT patients

Exclusion criteria

* Any dermatitis or infected skin over the sternum (Carnation patch) or left upper anterior thorax (Zio patch). * A sternal or thoracic incision that extends under the patch within 3 months from the date of enrollment. * Cognitive deficits that would interfere with the subject's ability to give informed consent or perform study testing

Design outcomes

Primary

MeasureTime frameDescription
ECG signal quality7 daysECG signal quality = scoring the ability of each system to record electrical activity from the atrium (P-waves). The Physician Event Committee will independently score the P-waves from all recordings.

Secondary

MeasureTime frameDescription
Skin comfort or discomfort: Was skin irritated?7 daysUser will rate skin comfort on pre-determined scale: None, Mild, Moderate, Severe.
Device Comfort7 daysWas device comfortable to wear? User will rate on a predetermined scale: Very Uncomfortable, Mildly Uncomfortable, Comfortable.
Device Stability and Contact7 daysDid the device stay in place in the chest location where it was attached for the time period indicated? Clinician will evaluate visually, and rate on a predetermined scale: Yes, No.
Diagnostic Yield7 daysDiagnostic Yield: proportion of patients for whom an arrhythmogenic source of symptoms is established or eliminated as a diagnosis.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026